The mutator phenotype theory can explain the complex morphology and behaviour of cancers

Cellular and Molecular Life Sciences

Volumn 59, Issue 6, 2002, Pages 950-958

  Bignold, L P ^a  

^a UNIVERSITY OF ADELAIDE   (Australia)

Author keywords

Cancer; Carcinogenesis; Genetic instability; Histopathology; Mutator

Indexed keywords

CANCER CELL; CANCER GROWTH; CARCINOGENESIS; CLONAL VARIATION; CYTOLOGY; GENE EXPRESSION; GENETIC STABILITY; GROWTH RATE; HISTOPATHOLOGY; HUMAN; HUMAN TISSUE; METASTASIS; MUTATION; PHENOTYPE; REVIEW; SOLID TUMOR;

ANIMALS; HUMANS; MODELS, GENETIC; MUTATION; NEOPLASMS; PHENOTYPE;

EID: 0036304331     PISSN: 1420682X     EISSN: None     Source Type: Journal    
DOI: 10.1007/s00018-002-8482-y     Document Type: Review

References (107)

1. Pathological consequences of chromosomal abnormality
2. The significance of mutation in relation to the origin of tumours: A review
3. The study of tumours in animals
4. Epigenetic carcinogens: Evaluation and risk assessment
5. The relation of genetics to the problems of cancer research
6. Of mice and men: A critical reappraisal of the two-stage theory of carcinogenesis
7. Cellular origin of cancer: Dedifferentiation or stem cell maturation arrest?
8. Recent advances in the biology of small cell lung cancer
9. Rationale and methods for the use of nude mice to study the biology and therapy of human cancer metastasis
10. Heterogeneity of human colon carcinoma
11. Tumour heterogeneity
12. The cellular basis of tumour progression
13. Heterogeneity amongst fibroblasts in the production of migration stimulating factor (MSF): Implications for cancer pathogenesis
14. Molecular pathology of breast cancer and its application to clinical management
15. Multistep carcinogenesis of breast cancer and tumour heterogeneity
16. Cell surface carbohydrates as prognostic markers in human carcinomas
17. Tumour markers in diagnosis and management
18. Oestrogen receptors in human breast cancer: Review of histopathological correlations and critique of histochemical methods
19. On the origin of multiple mutations in human cancers
20. The onset and extent of genomic instability in sporadic colorectal tumor progression
21. How many mutations does it take to make a tumor?
22. The clonal evolution of tumor cell populations
23. Tumor progression: Potential role of unstable genomic changes
24. It was a very good year for DNA repair
25. Molecular biology of cancer: Oncogenes
26. Genetic instabilty and cancer
27. p53 mutation and mitotic infidelity
28. Cancer cells exhibit a mutator phenotype
29. Chromosome segregation and cancer
30. Mutations of mitotic checkpoint genes in human cancers
31. Nucleotide excision repair DNA synthesis by excess DNA polymerase beta: A potential source of genetic instability in cancer cells
32. Nucleotide excision repair and cancer predisposition: A journey from man to yeast to mice
33. Cancer epigenetics comes of age
34. How aneuploidy may cause cancer and genetic instability
35. Telomeres, telomerase and cancer: An update
36. Telomere dysfunction promotes non-reciprocal translocations and epithelial cancers in mice
37. Mice without telomerase: What can they teach us about human cancer?
38. Cancers beget mutations versus mutations beget cancers
39. Genomic instability and tumor progression: Mechanistic considerations
40. On the origin of multiple mutations in human cancers
41. Significance of multiple mutations in cancer
42. Isolation and characterization of mutator strains of Escherichia coli K-12
43. Principles of molecular cell biology of cancer: Growth factors
44. Tumor invasion: Role of growth factor-induced cell motility
45. The role of polypeptide growth factors in human carcinomas: New targets for a novel pharmacological approach
46. The interphase nucleus
47. Nuclear lamins - Structural proteins with fundamental functions
48. Nuclear lamins: Their structure, assemby and interactions
49. The nuclear matrix in pathology
50. Lamins in disease: Why do ubiquitous nuclear envelope proteins give rise to tissue-specific disease phenotypes
51. Chromosome topology in mammalian interphase nuclei
52. Fluorescence in situ hybridization with comets
53. Fluorescence in situ hybridization for the detection of DNA and RNA
54. Macromolecular domains within the cell nucleus
55. Chromosome territories, interchromatin domain compartment, and nuclear matrix: An integrated view of the functional nuclear architecture
56. High resolution analysis of interphase chromosome domains
57. Chromosomes exhibit preferential positioning in nuclei of quiescent human cells
58. Fluorescence in situ hybridization with comets
59. The nuclear matrix from cells of different origin: Evidence for a common set of matrix proteins
60. The role of the nuclear matrix in the organization and function of DNA
61. The nuclear matrix in pathology
62. Half a century of 'the nuclear matrix'
63. Nuclear dreams: The malignant alteration of nuclear architecture
64. The nuclear pore complex
65. Transport into and out of the nucleus
66. Nuclear pores and nuclear assembly
67. Diverse nuclear transport pathways regulate cell proliferation and oncogenesis
68. The nuclear pore complex protein Nu88 is overexpressed in tumour cells
69. Alterations of nuclear pores in preneoplastic and neoplastic rat liver lesions induced by 2-acetylaminofluorene
70. Centrosome abnormalities, genomic instability and carcinogenic progression
71. Histone acetylation and cancer
72. Hypothesis: Some mutagens directly alter specific chromosomal proteins (DNA topoisomerase II and peripheral proteins) to produce chromosome stickiness, which causes chromosome aberrations
73. The Allium test - An alternative in environmental studies: The relative toxicity of metal ions
74. Mutations of cell cycle regulators: Biological and clinical implications for human neoplasia
75. Cytoskeletal changes in cell transformation and tumorigenesis
76. Chromatin, nuclear matrix and the cytoskeleton: Role of cell structure in neoplastic transformation
77. Gap junctional communication
78. Gap junction structure and the control of cell-to-cell communication
79. Role of inhibition of intercellular communication in carcinogenesis
80. Cellular communication via gap junctions
81. Connexin43 suppresses MFG-E8 while inducing contact growth inhibition of glioma cells
82. Aberrant expression and function of gap junctions during carcinogenesis
83. The role of gap junctional intercellular communication in neoplasia
84. Cell-cell communication in carcinogenesis
85. Cell junctions and the biological behaviour of cancer
86. Junctional intercellular communication pattern of cultured human breast cancer cells
87. Transdifferentiation induced by gene transfer
88. Id proteins at the cross-road of development and cancer
89. Genes and gene products that regulate proliferation and differentiation: Critical targets in carcinogenesis
90. Expression of an oncodevelopmental gene product (alpha-fetoprotein) during fetal development and adult oncogenesis